APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wilson's Disease

Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

Selected research

Market Outlook & Growth Opportunities

Global Wilson's Disease Market Outlook and Growth Opportunities 2026

28 December 2025193 pages

Choose your research edition.

Industry ResearchWilson's Disease Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Wilson's Disease Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Wilson's Disease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wilson's Disease Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Wilson's Disease Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

The classification of Wilson’s disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson’s disease. Penicillamine is the most successful drug used for the treatment of Wilson’s disease. Wilson’s disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson’s disease is Drugs Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.

This report provides an overview of the global Wilson's Disease market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Wilson's Disease and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Wilson's Disease revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Wilson's Disease market.

Wilson's Disease Segment by Company

Bausch Health

Teva

Endo International

Univar Solutions

MSN Laboratories

ANI Pharmaceuticals

APOTEX

Tsumura

Sinepharm

Taj Pharmaceutical

Kadmon Holdings

Wilson's Disease Segment by Type

Trientine

Penicillamine

Others

Wilson's Disease Segment by Application

Hospital

Drugs Stores

Others

Wilson's Disease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Wilson's Disease status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Wilson's Disease key companies, revenue, market share, and recent developments.

3. To split the Wilson's Disease breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Wilson's Disease market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Wilson's Disease significant trends, drivers, influence factors in global and regions.

6. To analyze Wilson's Disease competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wilson's Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wilson's Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wilson's Disease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Wilson's Disease industry.

Chapter 3: Detailed analysis of Wilson's Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Wilson's Disease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Wilson's Disease in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Wilson's Disease Industry Trends Table 2. Wilson's Disease Industry Drivers Table 3. Wilson's Disease Industry Opportunities and Challenges Table 4. Wilson's Disease Industry Restraints Table 5. Global Wilson's Disease Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Wilson's Disease Revenue Share by Company (2021-2026) Table 7. Global Wilson's Disease Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Wilson's Disease Key Company Manufacturing Base & Headquarters Table 9. Global Wilson's Disease Company, Product Type & Application Table 10. Global Wilson's Disease Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Wilson's Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Trientine Table 15. Significant Companies of Penicillamine Table 16. Significant Companies of Others Table 17. Global Wilson's Disease Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Wilson's Disease Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Wilson's Disease Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Wilson's Disease Sales Value Share by Type (2021-2026) Table 21. Global Wilson's Disease Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Drugs Stores Table 24. Significant Companies of Others Table 25. Global Wilson's Disease Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Wilson's Disease Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Wilson's Disease Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Wilson's Disease Sales Value Share by Application (2021-2026) Table 29. Global Wilson's Disease Sales Value Share by Application (2027-2032) Table 30. Global Wilson's Disease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Wilson's Disease Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Wilson's Disease Sales Value Share by Region (2021-2026) Table 33. Global Wilson's Disease Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Wilson's Disease Sales Value Share by Region (2027-2032) Table 35. Global Wilson's Disease Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Wilson's Disease Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Wilson's Disease Sales Value Market Share by Country (2021-2026) Table 38. Global Wilson's Disease Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Wilson's Disease Sales Value Market Share by Country (2027-2032) Table 40. Bausch Health Company Information Table 41. Bausch Health Business Overview Table 42. Bausch Health Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Bausch Health Wilson's Disease Product Portfolio Table 44. Bausch Health Recent Development Table 45. Teva Company Information Table 46. Teva Business Overview Table 47. Teva Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Teva Wilson's Disease Product Portfolio Table 49. Teva Recent Development Table 50. Endo International Company Information Table 51. Endo International Business Overview Table 52. Endo International Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Endo International Wilson's Disease Product Portfolio Table 54. Endo International Recent Development Table 55. Univar Solutions Company Information Table 56. Univar Solutions Business Overview Table 57. Univar Solutions Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Univar Solutions Wilson's Disease Product Portfolio Table 59. Univar Solutions Recent Development Table 60. MSN Laboratories Company Information Table 61. MSN Laboratories Business Overview Table 62. MSN Laboratories Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MSN Laboratories Wilson's Disease Product Portfolio Table 64. MSN Laboratories Recent Development Table 65. ANI Pharmaceuticals Company Information Table 66. ANI Pharmaceuticals Business Overview Table 67. ANI Pharmaceuticals Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. ANI Pharmaceuticals Wilson's Disease Product Portfolio Table 69. ANI Pharmaceuticals Recent Development Table 70. APOTEX Company Information Table 71. APOTEX Business Overview Table 72. APOTEX Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. APOTEX Wilson's Disease Product Portfolio Table 74. APOTEX Recent Development Table 75. Tsumura Company Information Table 76. Tsumura Business Overview Table 77. Tsumura Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Tsumura Wilson's Disease Product Portfolio Table 79. Tsumura Recent Development Table 80. Sinepharm Company Information Table 81. Sinepharm Business Overview Table 82. Sinepharm Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Sinepharm Wilson's Disease Product Portfolio Table 84. Sinepharm Recent Development Table 85. Taj Pharmaceutical Company Information Table 86. Taj Pharmaceutical Business Overview Table 87. Taj Pharmaceutical Wilson's Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Taj Pharmaceutical Wilson's Disease Product Portfolio Table 89. Taj Pharmaceutical Recent Development Table 90. Kadmon Holdings Company Information Table 91. Kadmon Holdings Business Overview Table 92. Kadmon Holdings Wilson's Disease Sales (Kg), Value (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 93. Kadmon Holdings Wilson's Disease Product Portfolio Table 94. Kadmon Holdings Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Wilson's Disease Product Image Figure 2. Global Wilson's Disease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wilson's Disease Market Size (2021-2032) & (US$ Million) Figure 4. Global Wilson's Disease Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Trientine Image Figure 8. Penicillamine Image Figure 9. Others Image Figure 10. Global Wilson's Disease Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Wilson's Disease Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Wilson's Disease Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Drugs Stores Image Figure 15. Others Image Figure 16. Global Wilson's Disease Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Wilson's Disease Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Wilson's Disease Sales Value Share by Application (2021-2032) Figure 19. Global Wilson's Disease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Wilson's Disease Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Wilson's Disease Sales Value (2021-2032) & (US$ Million) Figure 22. North America Wilson's Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Wilson's Disease Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Wilson's Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Wilson's Disease Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Wilson's Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Wilson's Disease Sales Value (2021-2032) & (US$ Million) Figure 28. South America Wilson's Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Wilson's Disease Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Wilson's Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Wilson's Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Wilson's Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Wilson's Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Trientine
  • Penicillamine
  • Others
Applications
  • Hospital
  • Drugs Stores
  • Others
Companies covered
  • Bausch Health
  • Teva
  • Endo International
  • Univar Solutions
  • MSN Laboratories
  • ANI Pharmaceuticals
  • APOTEX
  • Tsumura
  • Sinepharm
  • Taj Pharmaceutical
  • Kadmon Holdings

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Wilson's Disease Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Wilson's Disease Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Wilson's Disease Market Dynamics
  1. 2.1 Wilson's Disease Industry Trends
  2. 2.2 Wilson's Disease Industry Drivers
  3. 2.3 Wilson's Disease Industry Opportunities and Challenges
  4. 2.4 Wilson's Disease Industry Restraints
3 Wilson's Disease Market by Company
  1. 3.1 Global Wilson's Disease Company Revenue Ranking in 2025
  2. 3.2 Global Wilson's Disease Revenue by Company (2021-2026)
  3. 3.3 Global Wilson's Disease Company Ranking (2024-2026)
  4. 3.4 Global Wilson's Disease Company Manufacturing Base and Headquarters
  5. 3.5 Global Wilson's Disease Company Product Type and Application
  6. 3.6 Global Wilson's Disease Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Wilson's Disease Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Wilson's Disease Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Wilson's Disease Market by Type
  1. 4.1 Wilson's Disease Type Introduction
  2. 4.1.1 Trientine
  3. 4.1.2 Penicillamine
  4. 4.1.3 Others
  5. 4.2 Global Wilson's Disease Sales Value by Type
  6. 4.2.1 Global Wilson's Disease Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Wilson's Disease Sales Value by Type (2021-2032)
  8. 4.2.3 Global Wilson's Disease Sales Value Share by Type (2021-2032)
5 Wilson's Disease Market by Application
  1. 5.1 Wilson's Disease Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Stores
  4. 5.1.3 Others
  5. 5.2 Global Wilson's Disease Sales Value by Application
  6. 5.2.1 Global Wilson's Disease Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Wilson's Disease Sales Value by Application (2021-2032)
  8. 5.2.3 Global Wilson's Disease Sales Value Share by Application (2021-2032)
6 Wilson's Disease Regional Value Analysis
  1. 6.1 Global Wilson's Disease Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Wilson's Disease Sales Value by Region (2021-2032)
  3. 6.2.1 Global Wilson's Disease Sales Value by Region: 2021-2026
  4. 6.2.2 Global Wilson's Disease Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Wilson's Disease Sales Value (2021-2032)
  7. 6.3.2 North America Wilson's Disease Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Wilson's Disease Sales Value (2021-2032)
  10. 6.4.2 Europe Wilson's Disease Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Wilson's Disease Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Wilson's Disease Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Wilson's Disease Sales Value (2021-2032)
  16. 6.6.2 South America Wilson's Disease Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Wilson's Disease Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Wilson's Disease Sales Value Share by Country, 2025 VS 2032
7 Wilson's Disease Country-level Value Analysis
  1. 7.1 Global Wilson's Disease Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Wilson's Disease Sales Value by Country (2021-2032)
  3. 7.2.1 Global Wilson's Disease Sales Value by Country (2021-2026)
  4. 7.2.2 Global Wilson's Disease Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Wilson's Disease Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Wilson's Disease Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Wilson's Disease Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Wilson's Disease Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Wilson's Disease Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Wilson's Disease Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Wilson's Disease Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Wilson's Disease Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Wilson's Disease Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Wilson's Disease Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Wilson's Disease Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Wilson's Disease Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Wilson's Disease Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Wilson's Disease Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Wilson's Disease Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Wilson's Disease Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Wilson's Disease Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Wilson's Disease Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Wilson's Disease Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Wilson's Disease Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Wilson's Disease Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Wilson's Disease Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Wilson's Disease Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Wilson's Disease Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Wilson's Disease Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Wilson's Disease Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Wilson's Disease Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Wilson's Disease Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Wilson's Disease Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Wilson's Disease Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Wilson's Disease Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bausch Health
  2. 8.1.1 Bausch Health Company Information
  3. 8.1.2 Bausch Health Business Overview
  4. 8.1.3 Bausch Health Wilson's Disease Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bausch Health Wilson's Disease Product Portfolio
  6. 8.1.5 Bausch Health Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Wilson's Disease Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Wilson's Disease Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Endo International
  14. 8.3.1 Endo International Company Information
  15. 8.3.2 Endo International Business Overview
  16. 8.3.3 Endo International Wilson's Disease Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Endo International Wilson's Disease Product Portfolio
  18. 8.3.5 Endo International Recent Developments
  19. 8.4 Univar Solutions
  20. 8.4.1 Univar Solutions Company Information
  21. 8.4.2 Univar Solutions Business Overview
  22. 8.4.3 Univar Solutions Wilson's Disease Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Univar Solutions Wilson's Disease Product Portfolio
  24. 8.4.5 Univar Solutions Recent Developments
  25. 8.5 MSN Laboratories
  26. 8.5.1 MSN Laboratories Company Information
  27. 8.5.2 MSN Laboratories Business Overview
  28. 8.5.3 MSN Laboratories Wilson's Disease Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MSN Laboratories Wilson's Disease Product Portfolio
  30. 8.5.5 MSN Laboratories Recent Developments
  31. 8.6 ANI Pharmaceuticals
  32. 8.6.1 ANI Pharmaceuticals Company Information
  33. 8.6.2 ANI Pharmaceuticals Business Overview
  34. 8.6.3 ANI Pharmaceuticals Wilson's Disease Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ANI Pharmaceuticals Wilson's Disease Product Portfolio
  36. 8.6.5 ANI Pharmaceuticals Recent Developments
  37. 8.7 APOTEX
  38. 8.7.1 APOTEX Company Information
  39. 8.7.2 APOTEX Business Overview
  40. 8.7.3 APOTEX Wilson's Disease Revenue and Gross Margin (2021-2026)
  41. 8.7.4 APOTEX Wilson's Disease Product Portfolio
  42. 8.7.5 APOTEX Recent Developments
  43. 8.8 Tsumura
  44. 8.8.1 Tsumura Company Information
  45. 8.8.2 Tsumura Business Overview
  46. 8.8.3 Tsumura Wilson's Disease Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tsumura Wilson's Disease Product Portfolio
  48. 8.8.5 Tsumura Recent Developments
  49. 8.9 Sinepharm
  50. 8.9.1 Sinepharm Company Information
  51. 8.9.2 Sinepharm Business Overview
  52. 8.9.3 Sinepharm Wilson's Disease Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sinepharm Wilson's Disease Product Portfolio
  54. 8.9.5 Sinepharm Recent Developments
  55. 8.10 Taj Pharmaceutical
  56. 8.10.1 Taj Pharmaceutical Company Information
  57. 8.10.2 Taj Pharmaceutical Business Overview
  58. 8.10.3 Taj Pharmaceutical Wilson's Disease Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Taj Pharmaceutical Wilson's Disease Product Portfolio
  60. 8.10.5 Taj Pharmaceutical Recent Developments
  61. 8.11 Kadmon Holdings
  62. 8.11.1 Kadmon Holdings Company Information
  63. 8.11.2 Kadmon Holdings Business Overview
  64. 8.11.3 Kadmon Holdings Wilson's Disease Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kadmon Holdings Wilson's Disease Product Portfolio
  66. 8.11.5 Kadmon Holdings Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst